Transcription protein STAT1: Biology and relation to cancer

Folia Biologica

Volumn 53, Issue 1, 2007, Pages 1-6

  Adamkova L ^a   Souckova K ^a   Kovařík, Jan ^a  

^a MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

Author keywords

Aberrations in cancer; Biology; IFNs; STAT1

Indexed keywords

ALPHA INTERFERON; CASPASE 11; CISPLATIN; DOXORUBICIN; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 4; PROTEIN BAK; PROTEIN BAX; STAT1 PROTEIN; STAT2 PROTEIN;

APOPTOSIS; ARTHRITIS; BINDING SITE; BREAST CANCER; CANCER; CANCER INHIBITION; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CHROMOSOME 22; DRUG MECHANISM; GROWTH INHIBITION; HEAD CANCER; HOST SUSCEPTIBILITY; IMMUNITY; IMMUNOLOGICAL TOLERANCE; LEUKEMIA; LYMPHOMA; MALIGNANT TRANSFORMATION; MELANOMA; MOLECULAR BIOLOGY; NECK CANCER; NONHUMAN; PROTEIN DETERMINATION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN TARGETING; REVIEW;

EID: 33847418900     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Akira, S. (1999) Functional roles of STAT family proteins: lessons from knockout mice. Stem Cells 17, 138-146.
2. Aoki, N., Matsuda, T. (2002) A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus. Mol. Endocrinol. 16, 58-69.
3. Battle, T. E., Frank, D. A. (2002) The role of STATs in apoptosis. Curr. Mol. Med. 2, 381-392.
4. Boudny, V., Kocak, I., Lauerova, L., Kovarik, J. (2003) Interferon inducibility of STAT 1 activation and its prognostic significance in melanoma patients. Folia Biol. (Praha) 49, 142-146.
5. Boudny, V., Dusek, L., Adamkova, L., Chumchalova, J., Kocak, I., Fait, V, Lauerova, L., Krejci, E., Kovarik, J. (2005) Lack of STAT 1 phosphorylation at TYR 701 by IFNγ correlates with disease outcome in melanoma patients. Neoplasma 52, 330-337.
6. Bowman, T., Garcia, R., Turkson, J., Jove, R. (2000) STATs in oncogenesis. Oncogene 19, 2474-2488.
7. Briscoe, J., Kohlhuber, F., Muller, M. (1996) JAKs and STATs branch out. Trends Cell Biol. 6, 336-340.
8. Bromberg, J. F. (2001) Activation of STAT proteins and growth control. BioEssays 23, 161-169.
9. Bromberg, J., Darnell, J. E. Jr. (2000) The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19, 2468-2473.
10. Bromberg, J. F., Horvath, C. M., Wen, Z., Schreiber, R. D., Darnell, J. E. Jr. (1996) Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon α and interferon γ. Proc. Natl. Acad. Sci. USA 93, 7673-7678.
11. Bromberg, J. F., Fan, Z., Brown, C., Mendelsohn, J., Darnell, J. E. Jr. (1998) Epidermal growth factor-induced growth inhibition requires Stat1 activation. Cell Growth Differ. 9, 505-512.
12. Buettner, R., Mora, L. B., Jove, R. (2002) Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin. Cancer Res. 8, 945-954.
13. Chang, T. L., Peng, X., Fu, X. Y. (2000) Interleukin-4 mediates cell growth inhibition through activation of Stat1. J. Biol. Chem. 275, 10212-10217.
14. Chattedee-Kishore, M., Wright, K. L., Ting, J. P., Stark, G. R. (2000). How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene. EMBO J. 19, 4111-4122.
15. Chin, Y. E., Kitagawa, M., Su, W. C., You, Z. H., Iwamoto, Y., Fu, X. Y. (1996) Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WNF1/CIP1 mediated by STAT1. Science 272, 719-722.
16. Darnell, J. E. Jr., Kerr, I. M., Stark, Q. R. (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421.
17. de Hooge, A. S., van de Loo, F. A., Koenders, M. L., Bennink, M. B., Arntz, O. J., Kolbe, T., van den Berg, W. B. (2004) Local activation of STAT-1 and STAT-3 in the inflamed synovium during zymosan-induced arthritis: exacerbation of joint inflammation in STAT-1 gene-knockout mice. Arthritis Rheum. 50, 2014-2023.
18. Durbin, J. E., Hackenmiller, R., Simon, M. C., Levy, D. E. (1996) Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84, 443-450.
19. Durbin, J. E., Fernandez-Sesma, A., Lee, C. K., Rao, T. D., Frey, A. B., Moran, T. M., Vukmanovic, S., Garcia-Sastre, A., Levy, D. E. (2000) Type I IFN modulates innate and specific antiviral immunity. J. Immunol. 164, 4220-4228.
20. Hartman, S. E., Bertone, P., Nath, A. K., Royce, T. E., Gerstein, M., Weissman, S., Snyder, M. (2005) Global changes in STAT target selection and transcription regulation upon interferon treatments. Genes Dev. 19, 2953-2968.
21. Huang, Y. Q., Li, J. J., Karpatkin, S. (2000) Thrombin inhibits tumor cell growth in association with up-regulation of p21 (waf/cipl) and caspases via a p53-independent, STAT1-dependent pathway J. Biol. Chem. 275, 6462-6468.
22. Ihle, J. N., Kerr, I. M. (1995) Jaks, and Stats in signaling by the cytokine receptor superfamily. Trends Genet. 11, 69-74.
23. Ikeda, H., Old, L. J., Schreiber, R. D. (2002) The roles of IFN γ in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev. 13, 95-109.
24. Ivashkiv, L. B., Hu, X. (2004) Signaling by STATs. Arthritis Res. Ther. 6, 159-168.
25. Janjua, S., Stephanou, A., Latchman, D. S. (2002) The C-terminal activation domain of the STAT-1 transcription factor is necessary and sufficient for stress-induced apoptosis. Cell Death Differ. 9, 1140-1146.
26. Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., Schreiber, R. D. (1998) Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. USA 95, 7556-7561.
27. Koshiji, M., Adachi, Y., Sogo, S., Taketani, S., Oyaizu, N., Than, S., Inaba, M., Phawa, S., Hioki, K., Ikehara, S. (1998) Apoptosis of colorectal adenocarcinoma (COLO 201) by tumour necrosis factor-α (TNF-α) and/or interferon-γ (IFN-γ), resulting from down-modulation of Bcl-2 expression. Clin. Exp. Immunol. 111, 211-218.
28. Kovarik, A., Fojtova, M., Boudny, V., Adamkova, L., Lauerova, L., Kovarik, J. (2005) Interferon γ but not α induce SOCS 3 expression of human melanoma cell lines. Melanoma Res. 15, 481-488.
29. Kovarik, J., Boudny, V., Kocak, I., Lauerova, L., Fait, V, Vagundova, M. (2003) Malignant melanoma associates with deficient IFN-induced STAT 1 phosphorylation. Int. J. Mol. Med. 12, 335-340.
30. Kovarik, P., Mangold, M., Ramsauer, K., Heidari, H., Steinborn, R., Zotter, A., Levy, D. E., Muller, M., Decker, T. (2001) Specificity of signaling by STAT1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression. EMBO J. 20, 91-100.
31. Kumar, A., Commane, M., Flickinger, T. W., Horvath, C. M., Stark, G. R. (1997) Defective TNF-α-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science 278, 1630-1632.
32. Lee, C. K., Rao, D. T., Gertner, R., Gimeno, R., Frey, A. B., Levy, D. E. (2000a) Distinct requirements for IFNs and STAT1 in NK cell function. J. Immunol. 165, 3571-3577.
33. Lee, C. K., Smith, E., Gimeno, R., Gertner, R., Levy, D. E. (2000b) STAT1 affects lymphocyte survival and proliferation partially independent of its role downstream of IFN-γ. J. Immunol. 164, 1286-1292.
34. Lee, S. J., Zhou, T., Choi, C., Wang, Z., Benveniste, E. N. (2000c) Differential regulation and function of Fas expression on glial cells. J. Immunol. 164, 1277-1285.
35. Levy, D. E., Gilliland, D. G. (2000) Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice. Oncogene 19, 2505-2510.
36. Martone, R., Euskirchen, G., Bertone, P., Hartman, S., Royce, T. E., Luscombe, N. M., Rinn, J. L., Nelson, F. K., Miller, P., Gerstein, M., Weissman, S., Snyder, M. (2003) Distribution of NF-κB-binding sites across human chromosome 22. Proc. Natl. Acad. Sci. USA 100, 12247-12252.
37. Mascareno, E., El-Shafei, M., Maulik, N., Sato, M., Guo, Y., Das, D. K., Siddiqui, M. A. (2001) JAK/STAT signaling is associated with cardiac dysfunction during ischemia and reperfusion. Circulation 104, 325-329.
38. Meraz, M. A., White, J. M., Sheehan, K. C., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., Carver-Moore, K., DuBois, R. N., Clark, R., Aguet, M., Schreiber, R. D. (1996) Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84, 431-442.
39. Muller, M., Laxton, C., Briscoe, J., Schindler, C., Improta, T., Darnell, J. E. Jr, Stark, G. R., Kerr, I. M. (1993) Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-α and -γ signal transduction pathways. EMBO J. 12, 4221-4228.
40. Naka, T., Fujimoto, M., Kishimoto, T. (1999) Negative regulation of cytokine signaling: STAT-induced STAT inhibitor. Trends Biochem. Sci. 24, 394-398.
41. Nishibori, T., Tanabe, Y., Su, L., David, M. (2004) Impaired development of CD4+ CD25+ regulatory T cells in the absence of STAT1: increased susceptibility to autoimmune disease. J. Exp. Med. 199, 25-34.
42. Ossina, N. K., Cannas, A., Powers, V. C., Fitzpatrick, P. A., Knight, J. D., Gilbert, J. R., Shekhtman, E. M., Tomei, L. D., Umansky, S. R., Kiefer, M. C. (1997) Interferon-γ modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J. Biol. Chem. 272, 16351-16357.
43. Pansky, A., Hildebrand, P., Fasler-Kan, E., Baselgia, L., Ketterer, S., Beglinger, C., Heim, M. H. (2000) Defective Jak-STAT signal transduction pathway in melanoma cells resistant to growth inhibition by interferon-α. Int. J. Cancer 85, 720-725.
44. Ramana, C. V., Chatterjee-Kishore, M., Nguyen, H., Stark, G. R. (2000) Complex roles of Stat1 in regulating gene expression. Oncogene 19, 2619-2627.
45. Sahni, M., Raz, R., Coffin, J. D., Levy, D., Basilico, C. (2001) STAT1 mediates the increased apoptosis and reduced chondrocyte proliferation in mice overexpressing FGF2. Development 128, 2119-2129.
46. Schindler, C., Fu, X. Y., Improta, T., Aebersold, R., Darnell, J. E. Jr. (1992) Proteins of transcription factor ISGF-3: one gene encodes the 91-and 84-kDa ISGF-3 proteins that are activated by interferon α. Proc. Natl. Acad. Sci. USA 89, 7836-7839.
47. Seidel, H. M., Milocco, L. H., Lamb, P., Darnell, J. E. Jr., Stein, R. B., Rosen, J. (1995) Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc. Natl. Acad. Sci. USA 92, 3041-3045.
48. Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., Schreiber, R. D. (2001) IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410, 1107-1111.
49. Shin, E. C., Ahn, J. M., Kim, C. H., Choi, Y., Alin, Y. S., Kim, H., Kim, S. J., Park, J. H. (2001) IFN-γ induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway. Int. J. Cancer 93, 262-268.
50. Shuai, K. (1999) The STAT family of proteins in cytokine signaling. Prog. Biophys. Mol. Biol. 71, 405-422.
51. Shuai, K. (2000) Modulation of STAT signaling by STAT-interacting proteins. Oncogene 19, 2638-2644.
52. Shuai, K., Ziemiecki, A., Wilks, A. F., Harpur, A. G., Sadowski, H. B., Gilman, M. Z., Darnell, J. E. (1993) Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature 366, 580-583.
53. Stark, G. R., Kerr, I. M., Williams, B. R., Silverman, R. H., Schreiber, R. D. (1998) How cells respond to interferons. Annu. Rev. Biochem. 67, 227-264.
54. Starr, R., Hilton, D. J. (1999) Negative regulation of the JAK/STAT pathway. BioEssays 21, 47-52.
55. Stephanou, A., Brar, B. K., Scarabelli, T. M., Jonassen, A. K., Yellon, D. M., Marber, M. S., Knight, R. A., Latchman, D. S. (2000) Ischemia-induced STAT-1 expression and activation play a critical role in cardiomyocyte apoptosis. J. Biol. Chem. 275, 10002-10008.
56. Stephanou, A., Latchman, D. S. (2005) Opposing actions of STAT-1 and STAT-3. Growth Factors 23, 177-182.
57. Su, W. C., Kitagawa, M., Xue, N., Xie, B., Garofalo, S., Cho, J., Deng, C., Horton, W. A., Fu, X. Y. (1997) Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature 386, 288-292.
58. Suk, K., Kim, S., Kim, Y H., Kim, K. A., Chang, I., Yagita, H., Shong, M., Lee, M. S. (2001) IFN-γ/TNF-α synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic β cell death. J. Immunol. 166, 4481-4489.
59. Takayanagi, H., Kim, S., Matsuo, K., Suzuki, H., Suzuki, T., Sato, K., Yokochi, T., Oda, H., Nakamura, K., Ida, N., Wagner, E. F., Taniguchi, T. (2002) RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β. Nature 416, 744-749.
60. Takeda, K., Akira, S. (2000) STAT family of transcription factors in cytokine-mediated biological responses. Cytokine Growth Factor Rev. 11, 199-207.
61. ten Hoeve, J., de Jesus Ibarra-Sanchez, M., Fu, Y., Zhu, W., Tremblay, M., David, M., Shuai, K. (2002) Identification of a nuclear Stat1 protein tyrosine phosphatase. Mol. Cell. Biol. 22, 5662-5668.
62. Thomas, M., Finnegan, C. E., Rogers, K. M., Purcell, J. W., Trimble, A., Johnston, P. G, Boland, M. P. (2004) STAT1: a modulator of chemotherapy-induced apoptosis. Cancer Res. 64, 8357-8364.
63. Timofeeva, O. A., Plisov, S., Evseev, A. A., Peng, S., Jose-Kampfner, M., Lovvorn, H. N., Dome, J. S., Perantoni, A. O. (2006) Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis. Oncogene 25, doi:10.1038/sj.onc.1209742.
64. Townsend, P. A., Scarabelli, T. M., Davidson, S. M., Knight, R. A., Latchman, D. S., Stephanou, A. (2004) STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis. J. Biol. Chem. 279, 5811-5820.
65. Widschwendter, A., Tonko-Geymayer, S., Welte, T., Daxenbichler, G., Marth, C., Doppler, W. (2002) Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer. Clin. Cancer Res. 8, 3065-3074.
66. Wong, L. H., Krauer, K. G., Hatzinisiriou, I., Estcourt, M. J., Hersey, P., Tam, N. D., Edmondson, S., Devenish, R. J., Ralph, S. J. (1997) Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma. J. Biol. Chem. 272, 28779-28785.
67. Wormald, S., Hilton, D. J., Smyth, G. K., Speed, T. P. (2006a) Proximal genomic localization of STAT1 binding and regulated transcriptional activity. BMC Genomics 7, 254.
68. Wormald, S., Zhang, J. G., Krebs, D. L., Mielke, L. A., Silver, J., Alexander, W. S., Speed, T. P., Nicola, N. A., Hilton, D. J. (2006b) The comparative roles of suppressor of cytokine signaling-1 and -3 in the inhibition and desensitization of cytokine signaling. J. Biol. Chem. 281, 11135-11143.
69. Xia, Z., Baer, M. R., Block, A. W., Baumann, H., Wetzler, M. (1998) Expression of signal transducers and activators of transcription proteins in acute myeloid leukemia blasts. Cancer Res. 58, 3173-3180.
70. Xu, X., Fu, X. Y, Plate, J., Chong, A. S. (1998) IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression. Cancer Res. 58, 2832-2837.
71. You, M., Yu, D. H., Feng, G. S. (1999) Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway. Mol. Cell. Biol. 19, 2416-2424.